Becton Dickinson (BDX) Non-Current Assets (2009 - 2026)
Becton Dickinson's (BDX) quarterly Non-Current Assets came in at $42.8 billion in Q1 2026, down 6.51% year-on-year from $45.8 billion in Q1 2025, and down 6.2% on a QoQ basis from $45.7 billion in Q4 2025.
Becton Dickinson (BDX) Non-Current Assets (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has 18 years of Non-Current Assets data on file, last reported at $42.8 billion in Q1 2026.
- On a quarterly basis, Non-Current Assets fell 6.51% year-over-year to $42.8 billion in Q1 2026; TTM through Mar 2026 was $180.4 billion, a 0.85% decrease from a year earlier, with the FY2025 full-year figure at $46.1 billion, down 1.6% from the prior year.
- Non-Current Assets for Q1 2026 stood at $42.8 billion, down from $45.7 billion in the prior quarter.
- Over the last five years, Non-Current Assets for BDX reached as high as $46.8 billion in Q3 2024 and fell as low as $42.8 billion in Q1 2026.
- Historically, Non-Current Assets has averaged $44.8 billion across 5 years, with a median of $44.8 billion in 2022.
- Across the five-year window, Non-Current Assets increased 6.15% in 2024 and declined 6.51% in 2026, its largest moves.
- Year by year, Non-Current Assets stood at $45.0 billion in 2022, then decreased by 1.86% to $44.1 billion in 2023, then advanced by 4.28% to $46.0 billion in 2024, then dropped by 0.77% to $45.7 billion in 2025, then declined by 6.2% to $42.8 billion in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $42.8 billion in Q1 2026, $45.7 billion in Q4 2025, and $46.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 25.00 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 42.82 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 27.83 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 4.72 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 10.18 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 10.51 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 3.66 Bn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 13.00 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.82 Bn |
| Dec 31, 2025 | 45.65 Bn |
| Sep 30, 2025 | 46.07 Bn |
| Jun 30, 2025 | 45.91 Bn |
| Mar 31, 2025 | 45.80 Bn |
| Dec 31, 2024 | 46.01 Bn |
| Sep 30, 2024 | 46.82 Bn |
| Jun 30, 2024 | 43.38 Bn |
| Mar 31, 2024 | 43.82 Bn |
| Dec 31, 2023 | 44.12 Bn |
| Sep 30, 2023 | 44.10 Bn |
| Jun 30, 2023 | 44.43 Bn |
| Mar 31, 2023 | 44.81 Bn |
| Dec 31, 2022 | 44.95 Bn |
| Sep 30, 2022 | 44.79 Bn |
| Jun 30, 2022 | 43.65 Bn |
| Mar 31, 2022 | 44.63 Bn |
| Dec 31, 2021 | 45.06 Bn |
| Sep 30, 2021 | 45.03 Bn |
| Jun 30, 2021 | 44.80 Bn |